Dr Reddy's Laboratories today said it has launched a generic version of Pfizer's Geodon capsules in the US market, used in treating mental disorders, following approval from the US health regulator.
The company has launched Ziprasidone Hydrochloride capsules, a bioequivalent generic version of Geodon in the US market on March 2, 2012, following the approval by the United States Food and Drug Administration (USFDA), Dr Reddy's Laboratories said in a statement.
The Hyderabad-based firm has launched Ziprasidone Hydrochloride Capsules in strengths of 20 mg, 40 mg, 60 mg and 80 mg strengths, available in 60 count bottle size, it added.
According to IMS Health data, the Geodon brand had sales of nearly $1.34 billion for the 12 months ended December, 2011 in the US market.
